1. Overexpression of Pterin-4a-carbinolamine Dehydratase/Dimerization Cofactor of Hepatocyte Nuclear Factor 1 in Human Colon Cancer
- Author
-
Jean-Luc Van Laethem, Claus W. Heizmann, Donald Dassesse, Beat Thöny, Rally Eskinazi, Patrick Robberecht, Michal Svoboda, and Anne Résibois
- Subjects
Male ,Colon ,Colonic Neoplasms -- enzymology ,Biology ,Adenocarcinoma ,Hydro-Lyases -- biosynthesis ,medicine.disease_cause ,Polymerase Chain Reaction ,Pathology and Forensic Medicine ,Gene expression ,medicine ,otorhinolaryngologic diseases ,Tumor Cells, Cultured ,Humans ,RNA, Messenger ,Intestinal Mucosa ,Transcription factor ,Hydro-Lyases ,Intestinal Mucosa -- enzymology ,Aged ,Aged, 80 and over ,Tetrahydrobiopterin ,Sciences bio-médicales et agricoles ,Adenocarcinoma -- enzymology ,Middle Aged ,RNA, Messenger -- metabolism ,Molecular biology ,Immunohistochemistry ,Hepatocyte nuclear factors ,Biochemistry ,Cell culture ,Dehydratase ,Colonic Neoplasms ,Colon -- enzymology ,Female ,Carcinogenesis ,medicine.drug ,Regular Articles - Abstract
Pterin-4a-carbinolamine dehydratase (PCD) is a bifunctional protein also known as DCoH (dimerization co-factor of hepatocyte nuclear factor 1 (HNF1)). PCD/DCoH modulates the DNA binding specificity of HNF1, thus acting on its transcriptional activity. In addition, it participates in the recycling of tetrahydrobiopterin (BH(4)), an essential cofactor of several metabolic reactions. We investigated colorectal tumors and colorectal tumor cell lines as compared to normal colon samples in search of a potential differential expression of PCD/DCoH. Immunohistochemistry was conducted on 20 human colorectal tumors and 20 normal samples using a specific polyclonal antibody. Immunoblotting and RT-PCR analysis for PCD/DCoH and HNF1 were also performed on both human tissues and CACO-2 and HT-29 cell lines. All of the 20 tumors and both colon cancer cell lines presented a strong and widespread immunoreactivity for PCD/DCoH, contrasting with the absence of expression in the normal epithelia. We thus report the massive overexpression of PCD/DCoH in colon tumors, which is in striking contrast with the absence of staining in normal counterparts. The sharp contrast in the expression of a modulator of transcriptional activity between tumoral and normal cells may have a physiopathological role. PCD/DCoH could potentially be a new marker of malignant colon cells in vivo., Journal Article, Research Support, Non-U.S. Gov't, info:eu-repo/semantics/published
- Published
- 1999